- Home
- IVA vs TCMD Comparison
IVA vs TCMD Comparison
Compare IVA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- TCMD
- Stock Information
- Founded
- IVA 2011
- TCMD 1995
- Country
- IVA France
- TCMD United States
- Employees
- IVA N/A
- TCMD N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- IVA Health Care
- TCMD Health Care
- Exchange
- IVA Nasdaq
- TCMD Nasdaq
- Market Cap
- IVA 359.6M
- TCMD 288.7M
- IPO Year
- IVA 2020
- TCMD 2016
- Fundamental
- Price
- IVA $4.36
- TCMD $12.41
- Analyst Decision
- IVA Strong Buy
- TCMD Hold
- Analyst Count
- IVA 4
- TCMD 3
- Target Price
- IVA $10.50
- TCMD $13.50
- AVG Volume (30 Days)
- IVA 29.2K
- TCMD 269.0K
- Earning Date
- IVA 09-24-2025
- TCMD 08-04-2025
- Dividend Yield
- IVA N/A
- TCMD N/A
- EPS Growth
- IVA N/A
- TCMD N/A
- EPS
- IVA N/A
- TCMD 0.63
- Revenue
- IVA $14,591,573.00
- TCMD $298,851,000.00
- Revenue This Year
- IVA $44.22
- TCMD $7.96
- Revenue Next Year
- IVA $24.23
- TCMD $8.53
- P/E Ratio
- IVA N/A
- TCMD $19.85
- Revenue Growth
- IVA N/A
- TCMD 6.15
- 52 Week Low
- IVA $1.53
- TCMD $8.61
- 52 Week High
- IVA $4.36
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- IVA 74.37
- TCMD 62.68
- Support Level
- IVA $3.44
- TCMD $12.29
- Resistance Level
- IVA $3.58
- TCMD $12.98
- Average True Range (ATR)
- IVA 0.30
- TCMD 0.61
- MACD
- IVA 0.11
- TCMD 0.17
- Stochastic Oscillator
- IVA 100.00
- TCMD 66.51
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.